Structural insights into orthosteric and allosteric inhibition of non-canonical oncogenic PI3Kα mutants
Acta Pharmaceutica Sinica B · 2026-10
DOI: 10.1016/j.apsb.2026.10.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-10. Verfasst von Anqi Chen und 12 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanya Yazhou Bay Science and Technology City Administration.
Abstract (Originalsprache)
Blocking oncogenic PI3K α signaling represents a validated therapeutic strategy for solid tumors related to PIK3CA mutation. However, the pathogenic mechanisms beyond hotspot mutations remain poorly understood. Here, we combine cryogenic electron microscopy (cryo-EM), biochemical analyses, and molecular dynamics (MD) simulations to investigate the non-canonical R88Q and R348* alterations and their modulation by orthosteric and allosteric inhibitors. Cryo-EM analysis reveals that R88Q allosterically disrupts ABD–kinase coupling, increasing ABD dynamics and relieving p85 α -mediated autoinhibition without abrogating nSH2 binding. MD simulations further suggest that the R348* truncation markedly destabilizes the p85 α –p110 α interface, promoting inter-subunit separation and extreme flexibility. CYH33 occupies the orthosteric ATP-binding pocket, directly blocking catalytic activity. In R88Q, it additionally restrains the highly dynamic ABD, partially restoring autoinhibition. RLY-2608 and STX-478 allosterically engage a cryptic pocket formed by the catalytic and activation loops, thereby reinforcing the p110 α –iSH2 interface and promoting long-range conformational ordering of the ABD. These findings expand the landscape of PI3K α oncogenic activation and establish that orthosteric (CYH33) and allosteric (RLY-2608, STX-478) ligands reinforce an inhibitory conformation to counteract oncogenic PI3K α mutants in two mechanistically divergent modes.
Förderung
- Sanya Yazhou Bay Science and Technology City Administration
Zitieren
APA
Chen, A., Li, G., Liu, X., Qiu, Y., Zhao, F., Chen, Y., Wang, Y., Lv, M., Qu, P., Ding, J., Meng, L., Zhou, Q., & Wang, M. (2026). Structural insights into orthosteric and allosteric inhibition of non-canonical oncogenic PI3Kα mutants. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.10.025
Vancouver
Chen A, Li G, Liu X, Qiu Y, Zhao F, Chen Y, et al. Structural insights into orthosteric and allosteric inhibition of non-canonical oncogenic PI3Kα mutants. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.10.025
BibTeX
@article{Chen2026,
author = {Chen, Anqi and Li, Guanyi and Liu, Xiao and Qiu, Yue and Zhao, Fangqing and Chen, Yanyan and Wang, Yi and Lv, Mingcong and Qu, Pengrui and Ding, Jian and Meng, Linghua and Zhou, Qingtong and Wang, Ming-Wei},
title = {Structural insights into orthosteric and allosteric inhibition of non-canonical oncogenic PI3Kα mutants},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.10.025}
}
EUVIMED